Feed CBHD.DE
CB

Coloplast

CBHD.DE · XETRA

56.84 € +3.31% (+1.82 €)
1M -1.93%
Market Cap 97.6B kr
P/E Ratio 35.38x
Div. Yield 5.31%
ROE 19.70%

Bulios Fair Price

72.04 €

26.7% upside

Current Price

56.84 €

Undervalued Fair Value Overvalued

According to Bulios Fair Price, CBHD.DE is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Moderate
6/9
Valuation
55 /100
Fair
P/S -0.91x
P/B 7.32x
P/FCF 15.61x
Growth
45 /100
Stable
Rev. growth 7.19%
FCF growth 10.35%
Book val. growth 24.71%
Profitability
0 /100
Weak
Net margin 2.58%
Op. margin 6.99%
FCF margin 5.85%
Quality
62 /100
Average
ROE 19.70%
ROA 5.89%
Asset turnover -2.28x
Debt
30 /100
High
Current ratio 1.56x
Int. coverage -44.29x
Debt/Equity 1.78x
Stability
94 /100
Stable
Rev. volatility 3.89%
EPS volatility 16.84%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about CBHD.DE
Online

About the company

Coloplast A/S is a Danish company headquartered in Humlebæk. It specializes in the development, manufacturing, and sale of medical devices and products primarily focused on the areas of urology, ostomy care, and continence care. Their portfolio includes catheters, dressings, ostomy products, continence surgical instruments, and other products designed to care for patients with post-operative or permanent intestinal and urinary stomas, incontinence, and other urological and gastroenterological issues. Coloplast is known for its innovative approach to product development that helps improve the quality of life for patients with various health concerns. The company has a global presence and is recognized as a leader in the field of ostomy care and urological medical technologies. Shares of Coloplast A/S are publicly traded on the Danish stock exchange.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Gavin Wood

Employees

16,907

Headquarters

Humlebæk

Upcoming events

03 NOV

Earnings

Upcoming earnings report

50d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.